Infradure and Epodure are still going through hurdles. It's all about whether or not these treatments will make it to FDA approval. Infradure will be fast tracked and will be the one to watch because of the orphan status. If it passes, you can bet your #$%$ Epodure will as well...... huge markets with lame competition..
You are a pumper for this stock - do you get paid to do that by Ray? Last September you were talking about this going to be a 100 billion dollar company - you are hilarious. Then a month later you boast about your timing and that you sold at 16, 13 etc.